LACOSAMIDA TEVA 100 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lacosamida teva 100 mg

teva pharm. works private ltd. company (teva, hu) - ungaria - lacosamidum - compr. film. - 100mg - antiepileptice alte antiepileptice

LACOSAMIDA TEVA 150 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lacosamida teva 150 mg

teva pharm. works private ltd. company (teva, hu) - ungaria - lacosamidum - compr. film. - 150mg - antiepileptice alte antiepileptice

LACOSAMIDA TEVA 200 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lacosamida teva 200 mg

teva pharm. works private ltd. company (teva, hu) - ungaria - lacosamidum - compr. film. - 200mg - antiepileptice alte antiepileptice

LACOSAMIDA TEVA 50 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lacosamida teva 50 mg

teva pharm. works private ltd. company (teva, hu) - ungaria - lacosamidum - compr. film. - 50mg - antiepileptice alte antiepileptice

Finasterida comprimate 1 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

finasterida comprimate 1 mg

balkan pharmaceuticals srl, sc - finasteridum - comprimate - 1 mg

Vagimilt 100 mg + 100 mg capsule moi vaginale Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

vagimilt 100 mg + 100 mg capsule moi vaginale

miltonia health science ltd - clindamycinum + denumirea comuna internationala - capsule moi vaginale - 100 mg + 100 mg

GLIMBAX 0,074 g/100 ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glimbax 0,074 g/100 ml

doppel farmaceutici s.r.l. - italia - diclofenacum - apa de gura - 0,074g/100ml - medicamente pentru cavitatea bucala alte medicamente pt. tratamentul local al cavitatii bucale

GLIMBAX 0,074 g/100 ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glimbax 0,074 g/100 ml

doppel farmaceutici s.r.l. - italia - diclofenacum - apa de gura - 0,74mg/ml - medicamente pentru cavitatea bucala alte medicamente pt. tratamentul local al cavitatii bucale

Comirnaty Uniunea Europeană - română - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

Bovela Uniunea Europeană - română - EMA (European Medicines Agency)

bovela

boehringer ingelheim vetmedica gmbh - vii modificate diareea virală bovină-virus tip 1, non-citopatic părinte tulpina ke-9 și vii modificate diareea virală bovină virus tip 2, non-citopatic părinte tulpina ny-93 - produsele imunologice pentru bovidae, vaccinuri virale vii - pentru imunizarea activă a bovinelor la vârsta de 3 luni pentru a reduce hipertermie și pentru a minimiza reducerea de leucocite cauzată de diareea virală bovină virus (bvdv-1 și bvdv-2), și de a reduce virusul vărsare și viremiei cauzate de bvdv-2. pentru imunizarea activă a bovinelor împotriva bvdv-1 și bvdv-2, pentru a preveni nașterea vițeilor infectați persistent cauzate de infecția transplacentară.